Ligands of the GABAA Receptor Benzodiazepine Binding Site
Qinmi Wang,Yifan Han,Hong Xue
DOI: https://doi.org/10.1111/j.1527-3458.1999.tb00094.x
1999-01-01
CNS Drug Reviews
Abstract:CNS Drug ReviewsVolume 5, Issue 2 p. 125-144 Free Access Ligands of the GABAA Receptor Benzodiazepine Binding Site Qinmi Wang, Qinmi Wang Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong KongSearch for more papers by this authorYifan Han, Yifan Han Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong KongSearch for more papers by this authorHong Xue, Corresponding Author Hong Xue Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong KongDr. Hong Xue, Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong. Fax: (852) 2358-1552. E-mail: hxue@ust.hkSearch for more papers by this author Qinmi Wang, Qinmi Wang Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong KongSearch for more papers by this authorYifan Han, Yifan Han Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong KongSearch for more papers by this authorHong Xue, Corresponding Author Hong Xue Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong KongDr. Hong Xue, Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong. Fax: (852) 2358-1552. E-mail: hxue@ust.hkSearch for more papers by this author First published: 07 June 2006 https://doi.org/10.1111/j.1527-3458.1999.tb00094.xCitations: 23AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abbreviations: SAR structure-activity relationship QSAR quantitative structure-activity relationship BZ benzodiazepine CNS Central nervous system DI diazepam insensitive DS diazepam sensitive AChE acetylcholinesterase REFERENCES 1 Smith GB, Olsen RW. Functional domains of GABAA receptors. Trends Pharmacol Sci 1995; 16: 162– 168. CrossrefCASPubMedWeb of Science®Google Scholar 2 Davies PA, Hanna CM, Hales TG, Kirkness FE. Insensitivity to anesthetic agents conferred by a class of GABAA receptor subunit. Nature 1997; 385: 820– 823. CrossrefCASPubMedWeb of Science®Google Scholar 3 Sigel E, Buhr A. The benzodiazepine binding site of GABAA receptors. TIPS 1997; 18: 425– 429. CASPubMedWeb of Science®Google Scholar 4 Macdonald RL, Olsen RW. GABAA receptor channels. Ann Rev Neurosci 1994; 17: 569– 602. CrossrefCASPubMedWeb of Science®Google Scholar 5 McKernan RM, Whiting PJ. Which GABAA receptor subtypes really occur in the brain TINS 1996; 19: 139143. Google Scholar 6 Sieghart W. Structure and pharmacology of γ-aminobutyric acidA receptor subtypes. Pharmacol Rev 1995; 47(2): 181– 234. CASPubMedWeb of Science®Google Scholar 7 Gardner CR. Functional in vivo correlates of the benzodiazepine agonist-inverse agonist continuum. Prog Neurobiol 1988; 31: 425– 476. CrossrefCASPubMedWeb of Science®Google Scholar 8 Gardner CR, Tully WR, Hedgecock CJR. The rapidly expanding range of neuronal benzodiazepine receptor ligands. Prog Neurobiol 1993; 40: 1– 61. CrossrefCASPubMedWeb of Science®Google Scholar 9 Allen MS, Tan Y-C, Trudell ML, et al. Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site. J Med Chem 1990; 33: 2343– 2357. CrossrefCASPubMedWeb of Science®Google Scholar 10 Villar HO, Davies MF, Loew GH, Maguire PA. Molecular models for recognition and activation at the benzodiazepine receptor: A review. Life Sci 1991; 48: 593– 602. CrossrefCASPubMedWeb of Science®Google Scholar 11 Diaz-Arauzo H, Koehler KF, Hagen TJ, Cook JM. Synthetic and computer-assisted analysis of the pharmacophore for agonist at benzodiazepine receptors. Life Sci 1991; 49: 207– 216. CrossrefCASPubMedWeb of Science®Google Scholar 12 Schove LT, Perez JJ, Loew GH. Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem 1994; 2: 1029– 1049. CrossrefCASPubMedGoogle Scholar 13 Zhang W, Koehler KF, Zhang P, Cook JM. Development of a comprehensive pharmacophore model for the benzodiazepine receptor. Drug Des Dis 1995; 12: 193– 248. CASPubMedWeb of Science®Google Scholar 14 Fryer RI, Leimgruber W, Trybulski K. Quinazolines and 1,4-benzodiazepines. 90. Structure activity relationship between substituted 2-amino-N-(2-benzoyl-4-chlorophenyl)acetamides and 1,4-benzodiazepinones. J Med Chem 1982; 25: 1050– 1055. CrossrefCASPubMedWeb of Science®Google Scholar 15 Borea PA, Bonora A. Brain receptor binding and lipophilic character of benzodiazepines. Biochem Pharmacol 1983; 32: 603– 607. CrossrefCASPubMedWeb of Science®Google Scholar 16 Loew GH, Nienow JR, Poulsen M. Theoretical structure-activity studies of benzodiazepine analogues, requirements for receptor affinity and activity. Mol Pharmacol 1984; 26: 19– 34. CASPubMedWeb of Science®Google Scholar 17 Ghose AK, Crippen GM. Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method. Mol Pharmacol 1990; 37: 725– 734. CASPubMedWeb of Science®Google Scholar 18 Greco G, Novellino E, Silipo C, Vittoria A. Study of benzodiazepine receptor sites using a combined QSAR-CoMFA approach. Quant Struct-Act Relat 1992; 11: 461– 477. Wiley Online LibraryCASWeb of Science®Google Scholar 19 Gupta SP, Saha RN, Mulchandani V. Quantitative structure-activity relationship studies on benzodiazepine receptor binding: Recognition of active sites in receptor and modelling of interaction. J Mol Recognit 1992; 5: 75– 80. Wiley Online LibraryCASPubMedGoogle Scholar 20 Maddalena DJ, Johnston GAR. Prediction of receptor properties and binding affinity of ligands to benzodiazepine/GABAA receptors using artificial neural networks. J Med Chem 1995; 38: 715– 724. CrossrefCASPubMedWeb of Science®Google Scholar 21 So S-S, Karplus M. Genetic neural networks for quantitative structure-activity relationships: Improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors. J Med Chem 1996; 39: 5246– 5256. CrossrefCASPubMedWeb of Science®Google Scholar 22 Hasegawa K, Funatsu K. GA strategy for variable selection in QSAR studies: GAPLS and D-optimal designs for predictive QSAR model. J Mol Struct (Theochem) 1998; 425: 255– 262. CrossrefCASWeb of Science®Google Scholar 23 Doble A, Martin IL, Richards DA. GABA modulation predicts biological activity of ligands for the benzodiazepine receptor. Br J Pharmacol 1982; 76: 238– 244. Google Scholar 24 Wong G, Skolnick P. High affinity ligands for “diazepam-insensitive” benzodiazepine receptors. Eur J Pharmacol Mol Pharmacol Sec 1992; 225: 63– 68. CrossrefCASPubMedWeb of Science®Google Scholar 25 Korpi ER, Unsi-Oukari M, Wegelius K. Substrate specificity of diazepam-insensitive cerebellar [3H]Ro15-4513 binding sites. Eur J Pharmacol 1992; 213: 323– 329. CrossrefCASPubMedWeb of Science®Google Scholar 26 Gu Z-Q, Wong G, Dominguez C, De Costa BR, Rice KC, Skolnick PI. Synthesis and evaluation of imidazo[1,5-a][1,4]-benzodiazepine esters with high affinities and selectivities at diazepam insensitive (DI) benzodiazepine receptors. J Med Chem 1993; 36: 1001– 1006. CrossrefCASPubMedWeb of Science®Google Scholar 27 Wong G, Koehler KF, Skolnick P, et al. Synthetic and computer-assisted analysis of the structural requirements for selective, high-affinity ligand binding to diazepam-insensitive benzodiazepine receptors. J Med Chem 1993; 36: 1820– 1830. CrossrefCASPubMedWeb of Science®Google Scholar 28 Zhang P, Zhang W, Liu R, Harris B, Skolnick Cook JM. Synthesis of novel imidazobenzodiazepines as probes of the pharmacophore for “diazepam-insensitive” GABAA receptors. J Med Chem 1995; 38: 1679– 1688. CrossrefCASPubMedWeb of Science®Google Scholar 29 Zhang F, Koehler KF, Zhang P, Cook JM. Development of a comprehensive pharmacophore model for the benzodiazepine receptor. Drug Des Dis 1995; 12: 193– 248. CASPubMedWeb of Science®Google Scholar 30 Sharma RC, Singh P, Ojha TN. Oxadiazolylimidazobenzodiazepines as novel partial agonists with the benzodiazepine receptor—a QSAR analysis. Res Commun Chem Pathol Pharmacol 1993; 80: 357– 362. CASPubMedWeb of Science®Google Scholar 31 Martin LL, Tegeler JJ. Anti-anxiety agents and anticonvulsants. Ann Rep Med Chem 1988; 23: 19– 28. CrossrefCASWeb of Science®Google Scholar 2 Watjen F, Baker R, Engelstoff M, et al. Novel benzodiazepine receptor partial agonists: Oxadiazolylimidazobenzodiazepines. J Med Chem 1989; 32: 2282– 2291. CrossrefCASPubMedWeb of Science®Google Scholar 33 Braestrup C, Nielsen M, Olsen CE. Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc Natl Acad Sci USA 1980; 77: 2288– 2292. CrossrefCASPubMedWeb of Science®Google Scholar 34 Allen MS, Hagen TJ, Trudell ML, Codding PW, Skolnick P, Cook JM. Synthesis of novel 3-substituted carbolines as benzodiazepine receptor ligands: Probing the benzodiazepine receptor pharmacophore. J Med Chem 1988; 31: 1854– 1861. CrossrefCASPubMedWeb of Science®Google Scholar 35 Guzman F, Cain M, Larscheid P, et al. Biomimetic approach to potential benzodiazepine receptor agonists and antagonists. J Med Chem 1984; 27: 564– 570. CrossrefCASPubMedWeb of Science®Google Scholar 36 Dorey G, Poissonnet G, Potier M-C, et al. Synthesis and benzodiazepine receptor affinities of rigid analogs of 3-carboxy-beta-carbolines-demonstration that the benzodiazepine receptor recognizes preferentially the s-cis conformation of the 3-carboxy group. J Med Chem 1989; 32: 1799– 1804. CrossrefCASPubMedWeb of Science®Google Scholar 37 Lawson JA, Uyeno ET, Nienow J, Loew GH, Toll L. Structure-activity studies of beta-carboline analogs. Life Sci 1984; 34: 2007– 2013. CrossrefCASPubMedWeb of Science®Google Scholar 38 Hagen TH, Skolnick P, Cook JM. Synthesis of 6-substituted β-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists. J Med Chem 1987; 30: 750– 753. CrossrefCASPubMedWeb of Science®Google Scholar 39 Hollinshead SP, Trudell ML, Skolnick P, Cook JM. Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester. J Med Chem 1990; 33: 1062– 1069. CrossrefCASPubMedWeb of Science®Google Scholar 40 Allen MS, LaLoggia AJ, Dorn LJ, et al. Predictive binding of β-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach. J Med Chem 1992; 35: 4001– 4010. CrossrefCASPubMedWeb of Science®Google Scholar 41 Sharma RC, Ojha TN, Tiwari S, Singh P. Quantitative structure-activity relationship study of some benzodiazepine-receptor ligands having inverse agonist/antagonist and agonist actions. Drug Des Dis 1992; 9: 135– 143. CASPubMedGoogle Scholar 42 Hadjipavlou-Litina D, Hansch C. Quantitative structure-activity relationships of the benzodiazepines—A review and reevaluation. Chem Rev 1994; 94: 1483– 1505. CrossrefCASWeb of Science®Google Scholar 43 Fryer RI, Wang C-G, Chia N-C, Basile AS, Gu Z-Q, Skolnick P. Benzodiazepine-receptor (BZR) ligands: The conformational fit of agonist β-carbolines to an imidazobenzodiazepine template. Med Chem Res 1995; 5: 296– 307. CASWeb of Science®Google Scholar 44 Borea PA, Gilli G, Bertolasi V, Ferretti V. A stereochemical model accounting for receptor binding affinity and intrinsic activity of β-carbolines. Br J Pharmacol 1986; 86: 666. Google Scholar 45 Shannon HE, Hagen TJ, Guzman F, Cook JA. β-carbolines as antagonists of the discriminative stimulus effects of diazepam in rats. J Pharmacol Exp Ther 1988; 246: 275– 281. CASPubMedWeb of Science®Google Scholar 46 Previero A, Castellano C, Scuri R, Bianchi M, Rizzoli AA, Galzigna L. Synthesis and some properties of a homologous series of β-carboline-3-carboxylic esters. Farmaco 1989; 44: 435– 441. CASPubMedWeb of Science®Google Scholar 47 Malatynska E, Knapp R, Ikeda M, Yamamura HI. β-Carboline interactions at the BZ-GABA receptor chloride ionophore complex in the rat cerebral cortex. Brain Res Bull 1989; 22: 845– 848. CrossrefCASPubMedWeb of Science®Google Scholar 48 Andrews J, Stephens DN. The discriminative stimulus properties of the β-carboline ZK95962: A non-sedating benzodiazepine receptor ligand with anxiolytic-like properties. Psychopharmacology (Suppl) 1988; 96: 354– 354. Google Scholar 49 Yokoyama N, Ritter B, Neubert AD. 2-Arylpyrazolo[4,3-c]quinoline-3-ones: Novel agonist, partial agonist and antagonist of benzodiazepines. J Med Chem 1982; 25: 337– 339. CrossrefCASPubMedWeb of Science®Google Scholar 50 Fryer RI, Zhang P, Rios R, Gu ZQ, Basile AS, Skolnick P. Structure-activity relationship studies at the benzodiazepine receptor (BZR): A comparison of the substituent effects of pyrazoloquinolinone analogs. J Med Chem 1993; 36: 1669– 1673. CrossrefCASPubMedWeb of Science®Google Scholar 51 Cooper SJ, Kirkham TC, Estall LB. Pyrazoloquinolines: Second generation benzodiazepine receptor ligands have heterogeneous effects. Trends Pharmacol Sci 1987; 8: 180– 184. CrossrefCASWeb of Science®Google Scholar 52 Kemp JA, Marshall GR, Wong EHF, Woodruff GN. The affinities, potencies and efficacies of some benzodiazepine receptor agonists, antagonists and inverse agonists at rat hippocampal GABAA receptors. Br J Pharmacol 1987; 91: 601– 608. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 53 Bennett DA. Pharmacology of the pyrazolotype compounds: Agonist, antagonist and inverse agonist actions. Physiol Behav 1987; 41: 241– 245. CrossrefCASPubMedWeb of Science®Google Scholar 54 Savini L, Massarelli P, Nencini C, et al. High affinity central benzodiazepine receptor ligands: Synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones. Bioorg Med Chem 1998; 6: 389– 399. CrossrefCASPubMedWeb of Science®Google Scholar 55 Petke JD, Im HK, Im WB, et al. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine—Aminobutyric AcidA receptors. Mol Pharmacol 1992; 42: 294– 301. CASPubMedWeb of Science®Google Scholar 56 TenBrink RE, Im WB, Sethy VH, Tang AH, Carter DB. Antagonist, partial agonist, and full agonist imidazo[1,5-a]quinoxaline amides and carbamates acting through the GABAA/benzodiazepine receptor. J Med Chem 1994; 37: 758– 768. CrossrefCASPubMedWeb of Science®Google Scholar 57 Jacobsen EJ, TenBrink RE, Stelzer LS, et al. High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the γ-aminobutyric acid Abenzodiazepine receptor complex. J Med Chem 1996; 39: 158– 175. CrossrefCASPubMedWeb of Science®Google Scholar 58 Mickelson JW, Jacobsen EJ, Carter DB, et al. High-affinity γ-aminobutyric acid Abenzodiazepine ligands: Synthesis and structure-activity relationship studies of a new series of tetracyclic imidazoquinoxalines. J Med Chem 1996; 39: 4654– 4666. CrossrefCASPubMedWeb of Science®Google Scholar 59 Jacobsen EJ, Stelzer ES, Belonga KL, et al. 3-Phenyl-substituted imidazo[1,5-a]quinoxalin-4-ones and imidazo[1,5-a]quinoxaline ureas that have high affinity at the GABAA/benzodiazepine receptor complex. J Med Chem 1996; 39: 3820– 3836. CrossrefCASPubMedWeb of Science®Google Scholar 60 Gupta SP, Paleti A. Quantitative structure—Activity relationship studies on benzodiazepine receptor binding of some nonbenzodiazepine series of ligands. Quant Struct-Act Relat 1996; 15: 12– 16. Wiley Online LibraryCASWeb of Science®Google Scholar 61 Miksicek RJ. Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 1993; 44: 37– 43. CASPubMedWeb of Science®Google Scholar 62 Ai J, Dekermendjian K, Wang X, Nielsen M, Witt M-R. 6-Methylflavone, a benzodiazepine receptor ligand with antagonistic properties on rat brain and human recombinant GABAA receptors in vitro. Drug Dev Res 1997; 41: 99– 106. Wiley Online LibraryCASWeb of Science®Google Scholar 63 Medina JH, Viola H, Wolfman C, et al. Overview-flavonoids: A new family of benzodiazepine receptor ligands. Neurochem Res 1997; 22: 419– 425. CrossrefCASPubMedWeb of Science®Google Scholar 64 Marder M, Viola H, Wasowski C, et al. 6-Bromoflavone, a high affinity ligand for the central benzodiazepine receptors is a member of a family of active flavonoids. Biochem Biophys Res Comm 1996; 223: 384– 389. CrossrefCASPubMedWeb of Science®Google Scholar 65 Marder M, Zinczuk J, Colombo MI, et al. Synthesis of halogenated/nitrated flavone derivatives and evaluation of their affinity for the central benzodiazepine receptor. Bioorg Med Chem Lett 1997; 7: 2003– 2008. CrossrefCASWeb of Science®Google Scholar 66 Viola H, Wasowski C, Levi N, et al. Apigenin, a component of Mutricaria recutita flowers is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med 1995; 61: 213– 216. CrossrefCASPubMedWeb of Science®Google Scholar 67 Wolfman C, Viola H, Paladini AC, Dajas F, Medina JH. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor-ligand isolated from Passiflora-coerulea. Pharmacol Biochem Behav 1994; 47: 1– 4. CrossrefCASPubMedWeb of Science®Google Scholar 68 Häberlein H, Tschiersch K-P, Schäfer HL. Flavonoids from Leptospermum scoparium with affinity to the benzodiazepine receptor characterized by structure activity relationships and in vivo studies of a plant extract. Pharmazie 1994; 49: 912– 922. CASPubMedWeb of Science®Google Scholar 69 Clements-Jewery S, Danswan G, Gardner CR, et al. (Imidazo[1,2-a]pyrimidin-2-yl)-phenylmethanones and related compounds as potential nonsedative anxiolytics. J Med Chem 1988; 31: 1220– 1226. CrossrefCASPubMedWeb of Science®Google Scholar 70 Tully WR, Gardner CR, Westwood R. General approach leading to the development of imidazoquinoline and imidazopyrimidine benzodiazepine receptor ligands. Drug Dev Res 1991; 22: 279– 288. Wiley Online LibraryCASWeb of Science®Google Scholar 71 Gardner CR, Budhram P, Deacon RMJ, Thomson TA. The relationship between structure and efficacy at central benzodiazepine receptors of a series of imidazopyrimidines and imidazoquinolines. Drug Dev Res 1991; 22: 309– 320. Wiley Online LibraryCASWeb of Science®Google Scholar 72 Gardner CR. Pharmacological profiles of non-benzodiazepine ligands for central benzodiazepine receptors. Clin Neuropharmacol (Suppl 2) 1990; 13: 555– 556. Google Scholar 73 Gardner CR, Budhram P. Effects of agents which interact with central benzodiazepine binding sites on stress-induced ultrasounds in rat pups. Eur J Pharmacol 1987; 134: 275– 283. CrossrefCASPubMedWeb of Science®Google Scholar 74 Xue H, Chu R, Hang J, Lee P, Zheng H. Fragment of GABAA receptor containing key ligand-binding residues overexpressed in Escherichia coli. Protein Sci 1998; 7: 216– 219. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Citing Literature Volume5, Issue2June 1999Pages 125-144 ReferencesRelatedInformation